NCT06227728View on ClinicalTrials.gov

Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 22, 2024

Primary Completion Date

December 1, 2026

Study Completion Date

December 31, 2026

Conditions
Non Small Cell Lung CancerBreast CancerColorectal CancerGastric CancerLiver CancerAdvanced CancerImmune Checkpoint Inhibitor
Trial Locations (2)

Unknown

RECRUITING

University of Medicine and Pharmacy at HCMC, Ho Chi Minh City

NOT_YET_RECRUITING

Medical Genetics Institute, Ho Chi Minh City

Sponsors

Lead Sponsor

Gene Solutions
All Listed Sponsors
lead

Gene Solutions

INDUSTRY

NCT06227728 - Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer. | Biotech Hunter | Biotech Hunter